| Address:
|
1618 STATION STREET
|
| City: |
VANCOUVER |
|
State: |
|
|
Zip Code: |
V6A 1B6 |
| Telephone: |
|
|
Description of Business
|
Primary SIC Code:
3841 |
| (As filed with the SEC)
|
|
|
We are a specialty pharmaceutical and medical device company that discovers,
develops and markets innovative technologies primarily focused on acute and
surgical applications. We currently operate in two segments: Medical Products
and Pharmaceutical Technologies. Our Medical Products segment manufactures and
markets a wide range of single-use specialty medical products and medical device
components. These products are sold directly by us to end users or other
third-party medical products manufacturers. Our Pharmaceutical Technologies
segment focuses primarily on establishing product development and marketing
collaborations with major medical device, pharmaceutical or biomaterials
companies and to date has derived the majority of its revenue from royalties due
from partners that develop, market and sell products incorporating our
technologies. ... More ... |
| Date |
12-mos
Rolling EPS |
Dividend |
P/E
Ratio |
| 06/2010 | -0.52 | NA | N/E | | 03/2010 | -0.49 | NA | N/E | | 12/2009 | -0.27 | NA | N/E | | 09/2009 | -0.99 | NA | N/E | | 06/2009 | -8.21 | NA | N/E | | 03/2009 | -8.38 | NA | N/E | | 12/2008 | -8.71 | NA | N/E | | 09/2008 | -8.08 | NA | N/E |
Key Financial Ratios and Statistics |
FYE:
12/31 |
| Profitability |
2009 |
Leverage |
2009 |
| Net Inc/Comm Equity | -0.05 | Total Liab/Total Assets | 1.85 | | Net Inc/Total Assets | -0.06 | Total Liab/Inv Cap | 2.23 | | Net Inc/Inv Cap | -0.07 | Total Liab/Comm Equity | 1.35 | | Pretax Inc/Net Sales | -0.06 | Interest Coverage Ratio | 0.56 | | Net Inc/Net Sales | -0.08 | Curr Debt/Equity | NA | | Cash Flow/Net Sales | 0.08 | LTD/Equity | -1.84 | | SG&A/NetSales | 0.29 | Total Debt/Equity | -1.84 |
| Asset Utilization
|
|
Liquidity |
|
| Net Receivables Turnover | 8.89 | Quick Ratio | 1.49 | | Inventory Turnover | 3.10 | Current Ratio | 2.05 | | Inventory Day Sales | 0.01 | Net Rec/Curr Assets | 0.26 | | Net Sales/Work Cap | 4.20 | Inv/Curr Assets | 0.27 | | Net Sales/PP&E | 5.36 | | |
Income Statement (Millions) |
| |
6/30/2010
|
3/31/2010
|
12/31/2009
|
9/30/2009
|
|
Total Revenues(Net Sales)
|
61.89
|
63.34
|
63.56
|
63.24
|
|
Cost of Goods Sold
|
29.35
|
27.44
|
31.50
|
28.42
|
|
Selling & Admin Exps
|
22.78
|
16.89
|
22.40
|
17.92
|
|
Operating Income
|
-5.38
|
3.13
|
-8.02
|
4.02
|
|
Interest Exp
|
9.03
|
8.92
|
9.07
|
9.29
|
|
Pretax Income
|
-12.85
|
-5.49
|
-17.17
|
-5.74
|
|
Other Income
|
1.55
|
0.29
|
-0.72
|
0.17
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
-14.07
|
-6.70
|
-15.63
|
-7.80
|
|
Assets
|
6/30/2010
|
3/31/2010
|
12/31/2009
|
9/30/2009
|
|
Cash & Short Term Investments
|
35.15
|
48.61
|
57.32
|
53.76
|
|
Receivables - Total
|
35.07
|
34.84
|
33.54
|
31.96
|
|
Inventories - Total
|
37.86
|
38.24
|
35.54
|
37.95
|
|
Total Current Assets
|
110.61
|
124.98
|
129.70
|
127.75
|
|
Net Property, Plant & Equipment
|
52.18
|
49.60
|
52.18
|
55.29
|
|
Total Assets
|
334.37
|
356.88
|
370.06
|
377.13
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
51.83
|
59.25
|
63.19
|
56.99
|
|
Debt in Current Liabilities
|
NA
|
NA
|
NA
|
NA
|
|
Total Current Liabilities
|
51.83
|
59.25
|
63.19
|
57.20
|
|
Long-Term Debt
|
575.00
|
575.00
|
575.00
|
575.00
|
|
Total Liabilities
|
674.11
|
680.28
|
683.35
|
680.43
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
NA
|
NA
|
NA
|
NA
|
|
Preferred Stock
|
NA
|
NA
|
NA
|
NA
|
|
Common Stock
|
472.75
|
472.75
|
472.74
|
472.74
|
|
Retained Earnings
|
-887.31
|
-873.24
|
-866.54
|
-850.91
|
|
Treasury Stock
|
NA
|
NA
|
NA
|
NA
|
|
Total Stockholders' Equity
|
-339.74
|
-323.39
|
-313.29
|
-303.30
|
|
Total Liabilities and Stockholders' Equity
|
334.37
|
356.88
|
370.06
|
377.13
|
Cash Flow Summary (Millions) |
|
Categories
|
6/30/2010
|
3/31/2010
|
12/31/2009
|
9/30/2009
|
|
Net Cash Provided by Operating Activities
|
-10.52
|
-5.57
|
-0.85
|
2.95
|
|
Net Cash Provided by Investing Activities
|
-2.29
|
-0.77
|
-1.15
|
-1.90
|
|
Net Cash Provided by Financing Activities
|
0.00
|
-0.02
|
-0.21
|
-0.22
|
Annual Summary Data (Millions) |
| Year |
Sales |
Net
Income |
EPS |
| 12/2005 | 199.65 | -1.19 | 0.10 | | 12/2006 | 315.08 | 4.58 | 0.14 | | 12/2007 | 287.69 | -65.94 | -0.66 | | 12/2008 | 283.27 | -741.18 | -8.71 | | 12/2009 | 279.68 | -22.87 | -0.27 | | Growth Rates | 8.79 | -- | -- |
| Type |
Date(Q,M) |
No.
Owners |
Shares
Held (000s) |
%
Own |
| Institutional | 06/30/10 | 36 | 16,569 | 19.45 |
|
Report Date :
8/30/2010
 Copyright
2010, EDGAR Online, Inc. All
rights reserved. Replication or redistribution of EDGAR Online, Inc. content is
expressly prohibited without the prior written consent of EDGAR Online, Inc.
EDGAR Online, Inc. shall not be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
|
|
|